Relief Therapeutics Holding SA
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Relief Therapeutics Holding SA (RLFTF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.055x
Based on the latest financial reports, Relief Therapeutics Holding SA (RLFTF) has a cash flow conversion efficiency ratio of -0.055x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.23 Million) by net assets ($94.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Relief Therapeutics Holding SA - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Relief Therapeutics Holding SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Relief Therapeutics Holding SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Relief Therapeutics Holding SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Delek Automotive Systems Ltd
TA:DLEA
|
0.164x |
|
Heng Huat Resources Group Bhd
KLSE:0175
|
-0.020x |
|
LETUS CAPITAL ZY 1
F:7I4
|
N/A |
|
Sundance Strategies Inc
OTCQB:SUND
|
0.017x |
|
Zacatecas Silver Corp
PINK:ZCTSF
|
-0.018x |
|
DAVIDsTEA Inc.
PINK:DTEAF
|
-0.038x |
|
Vertex Resource Group Ltd
V:VTX
|
0.108x |
|
NuEnergy Gas Limited
F:NUB
|
-0.014x |
Annual Cash Flow Conversion Efficiency for Relief Therapeutics Holding SA (2016–2024)
The table below shows the annual cash flow conversion efficiency of Relief Therapeutics Holding SA from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $36.66 Million | $-2.92 Million | -0.080x | +76.41% |
| 2023-12-31 | $52.23 Million | $-17.61 Million | -0.337x | -103.25% |
| 2022-12-31 | $145.42 Million | $-24.13 Million | -0.166x | +15.68% |
| 2021-12-31 | $181.53 Million | $-35.72 Million | -0.197x | +27.73% |
| 2020-12-31 | $67.04 Million | $-18.25 Million | -0.272x | -434.75% |
| 2019-12-31 | $14.30 Million | $-728.00K | -0.051x | -75.35% |
| 2018-12-31 | $21.28 Million | $-618.00K | -0.029x | +48.15% |
| 2017-12-31 | $20.95 Million | $-1.17 Million | -0.056x | +56.88% |
| 2016-12-31 | $22.24 Million | $-2.89 Million | -0.130x | -- |